评估临床变量对埃诺沙巴林剂量和抗Xa因子度的影响
Arnau Torrent-Rodríguez1, Carla Bastida2, Dolors Soy-Muner1
1Pharmacy Service, Department of Medicines, Hospital Clinic de Barcelona, Barcelona, Spain.
European journal of hospital pharmacy : science and practice
|December 16, 2025
概括
肥胖症显著影响埃诺沙的剂量,使抗Xa因子 (anti-Xa) 的水平变得不可预测. 针对肥胖患者的抗Xa监测可以改善治疗药物效果和患者安全.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 血栓形成的管理
背景情况:
- 低分子量肝素Enoxaparin是静脉血栓塞栓症的标准治疗方法.
- 常规的抗Xa因子 (抗Xa) 监测不是标准的,但可能会使肥胖或功能障碍患者等高风险群体受益.
研究的目的:
- 评估临床因素如何影响埃诺沙巴林剂量.
- 评估抗Xa监测的实际有效性.
主要方法:
- 对146名接受治疗的住院成年人进行了回顾性研究.
- 剂后4小时测量出抗Xa水平的峰值.
- 多重线性回归确定了抗Xa度的预测因素.
主要成果:
- 埃诺沙巴林剂量和肥胖程度独立地预测了抗Xa水平的峰值.
- 剂量度相关性在非肥胖患者中很强 (r=0.56),但在肥胖患者中很弱 (r=0.16).
- 只有46.6%的人达到治疗性抗Xa度;剂量调整改善了79.2%的监测患者的水平.
结论:
- 肥胖会改变埃诺沙巴林的药理动力学,降低剂量可预测性.
- 针对肥胖患者推针对性抗Xa监测和结构化方案,以提高安全性和疗效.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
215
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
215
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Time Course of Drug Effect
2.6K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.6K


